Trial Profile
To investigate the efficacy of Tenegliptin as an Add-on to antidiabetic therapy in patients with Type-2 Diabetes Mellitus- A real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2016
Price :
$35
*
At a glance
- Drugs Teneligliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 23 Sep 2016 New trial record